Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services, has received two separate orders for the short-term suspension of drug licenses at specific store locations. These administrative actions, effective as of May 20, 2026, involve sites in Telangana and Karnataka. The total estimated potential revenue impact from these temporary closures is approximately Rs 5.03 lacs.
Details of License Suspensions
MedPlus Health Services has disclosed that its subsidiary, Optival Health Solutions Private Limited, is currently subject to temporary drug license suspensions at two retail locations. The regulatory orders were received on May 20, 2026, for stores located in the states of Telangana and Karnataka, citing contraventions under the Drugs and Cosmetics Act, 1940.
Store Locations and Financial Impact
The suspensions affect two specific outlets with varying durations of inactivity. The store in Market Road, Narsapur, Telangana, faces a two-day suspension, resulting in a potential revenue loss of Rs 0.18 lacs. Simultaneously, the store in Vinobha Nagar, Karnataka, is under a five-day suspension, contributing a potential revenue loss of Rs 4.85 lacs. The aggregate impact on the company’s financial operations is estimated at Rs 5.03 lacs.
Source: BSE
